CLEVELAND, Nov. 21, 2017 /PRNewswire/ -- ViewRay, Inc.
(NASDAQ: VRAY) announced today that Chris
Raanes, Chief Executive Officer, and Ajay Bansal, Chief Financial Officer are
scheduled to participate in two upcoming investor conferences.
The first conference is the 29th Annual Piper Jaffray Healthcare
Conference in New York on
November 29, 2017. This conference
includes a fireside chat presentation and will allow institutional
investors to meet with the Company.
Event:
|
29th Annual Piper
Jaffray Healthcare Conference
|
Date:
|
Wednesday, November
29, 2017
|
Time:
|
12:00 p.m.
ET
|
The second conference is the Global Mizuho Investor Conference
NY 2017 in New York on
December 4, 2017. This conference
will allow institutional investors to meet with the Company but
does not include a formal presentation.
Event:
|
Global Mizuho
Investor Conference NY 2017
|
Date:
|
Monday, December 4,
2017
|
An audio webcast of the Company's presentation at the Piper
Jaffray conference will be available on the investor relations
section of ViewRay's website at www.viewray.com. A replay of the
webcast will be available for 14 days after the date of the
presentation.
About ViewRay
ViewRay®, Inc. (Nasdaq: VRAY), designs,
manufactures and markets the MRIdian® radiation therapy
system. MRIdian is built upon a proprietary high-definition MR
imaging system designed from the ground up to address the unique
challenges and clinical workflow for advanced radiation oncology.
Unlike MR systems used in diagnostic radiology, MRIdian's
high-definition MR was purposely built to deliver high-precision
radiation without unnecessary beam distortion, and consequently,
help to mitigate skin toxicity and other safety concerns that may
otherwise arise when high magnetic fields interact with radiation
beams. ViewRay and MRIdian are registered trademarks of
ViewRay, Inc.
View original
content:http://www.prnewswire.com/news-releases/viewray-to-participate-in-upcoming-conferences-300560485.html
SOURCE ViewRay, Inc.